Lancet, J., Ravandi, F., Ricklis, R., Cripe, L., Kantarjian, H., Giles, F., . . . Karp, J. (2011). A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia. Leukemia.
Styl ChicagoLancet, JE, et al. "A Phase Ib Study of Vosaroxin, an Anticancer Quinolone Derivative, in Patients With Relapsed or Refractory Acute Leukemia." Leukemia 2011.
Citace podle MLALancet, JE, et al. "A Phase Ib Study of Vosaroxin, an Anticancer Quinolone Derivative, in Patients With Relapsed or Refractory Acute Leukemia." Leukemia 2011.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..